| Literature DB >> 34956433 |
Zhaoyang Guo1, Xiaolin Wu1, Shuai Yang1, Chang Liu1, Youfu Zhu1, Nana Shen2, Zhu Guo1, Weiliang Su1, Yan Wang1, Bohua Chen1, Hongfei Xiang1.
Abstract
OBJECTIVE: The current study aimed to explore the efficacy of Zero profile intervertebral fusion system (Zero-P) and traditional anterior plate cage system (PC) in the treatment of cervical spondylotic myelopathy (CSM). Further, the present study evaluated effects of the treatments on medical security, height of intervertebral disc, adjacent-level ossification development (ALOD), and adjacent segmentation disease (ASD) through a systematic retrospective analysis.Entities:
Mesh:
Year: 2021 PMID: 34956433 PMCID: PMC8702348 DOI: 10.1155/2021/3960553
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Figure 1(a) Preoperative cervical curvature funnel diagram; (b) postoperative cervical curvature funnel diagram; (c) funnel diagram for interbody fusion rate; (d) preoperative DHI funnel diagram; (e) postoperative DHI funnel diagram; (f) postoperative dysphagia funnel diagram; (g) ALOD funnel diagram; (h) ASD funnel diagram; (i) postoperative sinking rate funnel diagram of fusion cage; (j) screw loosening funnel diagram (IV) evaluation of publication bias.
Figure 2Flowchart of literature screening.
Quality evaluation of RCT.
| First author and author (year of publication) | Country | Type of study | Surgical segment | Sample size | Gender (M/F) | Age ( | Follow-up time ( | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Zero-P | PC | Zero-P | PC | Zero-P | PC | Zero-P | PC | ||||
| Li et al. (2015) [ | China | Randomized controlled trial | 1 | 12 | 11 | 7/5 | 5/6 | 50.3 ± 8.8 | 51.1 ± 6.7 | 24 | 24 |
| He et al. (2018) [ | China | Randomized controlled trial | 2 | 52 | 52 | 28/24 | 27/25 | 55.4 ± 12.4 | 59.5 ± 12.6 | 24 | 24 |
| Yan and Nie (2018) [ | China | Randomized controlled trial | 1 | 49 | 49 | 29/20 | 29/20 | 43.1 ± 5.3 | 43.3 ± 5.2 | 12 | 12 |
| Chen et al. (2016) [ | China | Randomized controlled trial | 3 | 34 | 38 | 21/13 | 25/13 | 56.9 ± 5.9 | 56.2 ± 5.7 | 12 | 12 |
| Qizhi et al. (2016) [ | China | Randomized controlled trial | 2 | 16 | 14 | 11/5 | 9/5 | 48.13 ± 5.98 | 46.79 ± 5.15 | 32.4 | 32.4 |
| Scholz et al. (2020) [ | Germany | Randomized controlled trial | 1 | 21 | 20 | 13/8 | 11/9 | 58 | 58 | 24 | 24 |
| Alimi et al. (2016) [ | United States | Nonrandomized retrospective study | 1, 2, 3 | 69 | 35 | 35/34 | 18/17 | 58.2 ± 1.45 | 51.5 ± 1.95 | 15.7 ± 1.23 | 14.8 ± 2.13 |
| Li et al. (2017) [ | China | Nonrandomized retrospective study | 1, 2, 3, 4 | 68 | 70 | 41/27 | 45/25 | 50.6 ± 7.5 | 51.3 ± 7.9 | 29.7 ± 6.5 | 30.8 ± 6.6 |
| Liu et al. (2016) [ | China | Nonrandomized retrospective study | 3, 4 | 28 | 32 | 10/18 | 12/20 | 56.6 ± 9.7 | 57.5 ± 9.5 | 23.3 ± 6.9 | 24.2 ± 6.4 |
| Cho et al. (2015) [ | Korea | Nonrandomized retrospective study | 1 | 21 | 29 | 12/9 | 19/10 | 56.1 ± 12 | 55.2 ± 10.4 | 24 | 24 |
| Shi et al. (2016) [ | China | Nonrandomized retrospective study | 1 | 68 | 60 | 33/35 | 24/36 | 47.4 ± 7.0 | 46.5 ± 6.8 | 48 | 48 |
| Sun et al. (2020) [ | China | Nonrandomized retrospective study | 3 | 27 | 34 | 15/12 | 25/9 | 54.7 ± 7.6 | 56.4 ± 7.5 | 60 | 60 |
| Wang et al. (2014) [ | China | Nonrandomized retrospective study | 1, 2 | 30 | 33 | 18/12 | 14/19 | 56.8 ± 11.0 | 54.0 ± 10.0 | 24.1 ± 7.8 | 23.8 ± 8.2 |
| Yang et al. (2015) [ | China | Nonrandomized retrospective study | 1, 2, 3 | 30 | 32 | 20/10 | 22/10 | 44.1 ± 5.8 | 42.8 ± 6.1 | 30.6 ± 2.4 | 33.1 ± 3.0 |
| Shen et al. (2018) [ | China | Nonrandomized retrospective study | 1, 2, 3 | 27 | 31 | 16/11 | 14/17 | 52.3 ± 9.2 | 54.7 ± 9.2 | 37.2 ± 22.8 | 46.8 ± 21.6 |
| Yun et al. (2016) [ | Korea | Nonrandomized retrospective study | 3 | 31 | 32 | 29/3 | 22/9 | 53.29 ± 7.55 | 54.18 ± 9.87 | 12.77 ± 7.85 | 13.62 ± 9.21 |
| Zhang et al. (2016) [ | China | Nonrandomized retrospective study | 1, 2 | 22 | 27 | 11/12 | 13/14 | 48.6 ± 8.1 | 52.7 ± 8.3 | 24 | 24 |
Figure 3Literature quality evaluation chart of RCT.
Newcastle-Ottawa Scale evaluation of observational studies.
| Methodological quality assessment for inclusion in observational studies (score) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Research | Study population selection | Intergroup comparison (2 points) | Measurement of exposure factors | Total (9 points) | |||||
| A (1 point) | B (1 point) | C (1 point) | D (1 point) | E (1 point) | F (1 point) | G (1 point) | |||
| Alimi, 2016 | 1 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 7 |
| Li, 2017 | 1 | 1 | 1 | 0 | 2 | 0 | 1 | 0 | 6 |
| Liu, 2016 | 1 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 7 |
| Cho, 2015 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 |
| Shi, 2016 | 1 | 1 | 1 | 1 | 2 | 0 | 1 | 0 | 7 |
| Sun, 2020 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 8 |
| Wang, 2014 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 8 |
| Yang, 2015 | 1 | 1 | 1 | 0 | 2 | 0 | 1 | 0 | 6 |
| Yong, 2018 | 1 | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 8 |
| Yun, 2016 | 1 | 1 | 1 | 0 | 2 | 0 | 1 | 0 | 6 |
| Zhang, 2016 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 7 |
A, case determination being appropriate; B, case representation; C, selection of control; D, determination of control; E, determination of exposure factors; F, determination of case and control exposure factors being the same; G, response rate.
Meta-analysis results of included studies.
| Research projects | Number of studies | Sample size | Results | Heterogeneity | Statistical methodology | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Zero-P | PC |
| OR/WMD | CI 95 per cent | |||||
| Cervical curvature | Preoperative | 5 | 321 | 150 | 171 | 0.69 | −0.23 | −1.38, 0.92 | 0.72 (0%) | WMD (IV, fixed) |
| Postoperative | 5 | 321 | 150 | 171 | 0.59 | −0.38 | −1.77, 1.01 | 0.85(0%) | WMD (IV, fixed) | |
| Intervertebral fusion rate | 6 | 383 | 184 | 199 | 0.38 | 0.76 | 0.27, 2.48 | 0.97(0%) | OR (M-H, fixed) | |
| DHI | Preoperative | 5 | 380 | 181 | 199 | 0.65 | −0.04 | −0.14, 0.22 | 0.66(0%) | WMD (IV, fixed) |
| Postoperative | 5 | 380 | 181 | 199 | 0.675 | 0.06 | −0.22, 0.34 | 0.03(63%) | WMD (IV, random) | |
| Dysphagia | 13 | 904 | 458 | 446 | <0.00001 | 0.40 | 0.28, 0.58 | 0.62(0%) | OR (M-H, fixed) | |
| ALOD | 2 | 133 | 63 | 70 | 0.001 | 0.09 | 0.02, 0.39 | 0.57(0%) | OR (M-H, fixed) | |
| ASD | 6 | 440 | 219 | 221 | 0.02 | 0.42 | 0.20, 0.86 | 0.20(32%) | OR (M-H, fixed) | |
| Sinking rate of the cage | 5 | 448 | 221 | 227 | 0.50 | 1.41 | 0.52, 3.82 | 0.09(51%) | OR (M-H, random) | |
| Screw loosening | 3 | 326 | 164 | 162 | 0.0009 | 0.20 | 0.08, 0.52 | 0.25(28%) | OR (M-H, fixed) | |
Figure 4Cervical curvature before and after surgery.
Figure 5Intervertebral fusion rate.
Figure 6Preoperative DHI.
Figure 7(a) Postoperative DHI and (b) sensitivity analysis on postoperative DHI.
Figure 8Postoperative dysphagia.
Figure 9Postoperative ALOD.
Figure 10Postoperative ASD.
Figure 11(a) Fusion sinking rate after surgery. (b) Sensitivity analysis of fusion sinking rate after operation.
Figure 12Screw loosening after operation.